论文部分内容阅读
近半年来,在大陆宏观经济回升不力,多数行业增长趋缓的大背景下,医药工业却保持了比较旺盛的增长势头,不仅企业生产增长明显,销售稳中有升,企业的经营环境、运营状况也有较大改善,已经成为各行业中一个引人瞩目的增长亮点。另外,大陆社会保障体制和医疗保障制度的改革为医药工业提供了新的发展机遇,使医药制造业正在成为海内外投资者日益关注的领域之一。
In the past six months, under the background that the mainland’s macroeconomic recovery has been weak and the growth of most industries has slowed down, the pharmaceutical industry has maintained a relatively strong growth momentum. Not only has the company’s production growth increased significantly, sales have steadily increased, and the company’s operating environment and operations have improved. The situation has also been greatly improved and it has become an eye-catching growth highlight in various industries. In addition, the reform of the social security system and medical security system in the mainland has provided new opportunities for development in the pharmaceutical industry, making the pharmaceutical manufacturing industry one of the areas of increasing concern to investors at home and abroad.